Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Composition for resisting atherosclerosis myocardial-cerebral ischemia and application

A technology for atherosclerosis and heart and brain ischemia, which is applied in the direction of drug combination, cardiovascular system diseases, active ingredients of anhydride/acid/halide, etc., can solve the problem of non-prevention and prevention of atherosclerosis, heart and brain ischemia recurring , not suitable for long-term use, etc., to achieve the effect of protecting vascular endothelial cells, preventing heart and brain ischemia hypoxic oxidative stress damage, and reducing platelet aggregation

Inactive Publication Date: 2017-03-08
XINXIANG MEDICAL UNIV
View PDF3 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, the above-mentioned 7 kinds of traditional Chinese medicine preparations all contain poisonous traditional Chinese medicine according to the Pharmacopoeia, and are not suitable for long-term use; Continue to develop, heart and brain ischemia still occurs repeatedly

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Composition for resisting atherosclerosis myocardial-cerebral ischemia and application
  • Composition for resisting atherosclerosis myocardial-cerebral ischemia and application

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0060] A composition for resisting atherosclerosis, cardiocerebral ischemia, which comprises the following raw materials prepared in parts by weight: 10 parts of ginseng, 30 parts of salvia miltiorrhiza, 1 part of gamma aminobutyric acid, 5 parts of haematococcus, 20 parts of grape seed, 1 part of taurine, 1 part of functional red yeast rice, 20 parts of earthworm, 20 parts of psyllium.

Embodiment 2

[0062] A composition for resisting atherosclerosis, cardiocerebral ischemia, which comprises the following raw materials prepared in parts by weight: 100 parts of ginseng, 150 parts of salvia miltiorrhiza, 6 parts of gamma aminobutyric acid, 20 parts of haematococcus, 120 parts of grape seeds, 15 parts of taurine, 20 parts of functional red yeast rice, 100 parts of earthworm, 150 parts of psyllium.

Embodiment 3

[0064] A composition for resisting atherosclerosis, cardiocerebral ischemia, which comprises the following raw materials prepared in parts by weight: 55 parts of ginseng, 90 parts of salvia miltiorrhiza, 3.5 parts of gamma aminobutyric acid, 12.5 parts of haematococcus, 70 parts of grape seeds, 8 parts of taurine, 10.5 parts of functional red yeast rice, 60 parts of earthworm, 85 parts of psyllium.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention belongs to a composition for resisting atherosclerosis myocardial-cerebral ischemia and an application. The composition is prepared from the following raw materials in parts by weight: 10-100 parts of ginseng, 30-150 parts of salvia miltiorrhiza, 1-6 parts of gamma-aminobutyric acid, 5-20 parts of haematococcus, 20-120 parts of grape seeds, 1-15 parts of taurine, 1-20 parts of functional red koji, 20-100 parts of earthworms and 20-150 parts of semen plantaginis. The composition has the advantages of safety and obvious effect, stable quality, convenience in carrying and fitness for long-term taking of patients suffering from atherosclerosis myocardial-cerebral ischemia.

Description

technical field [0001] The invention belongs to the technical field of traditional Chinese medicine, and in particular relates to an anti-atherosclerosis cardio-cerebral ischemia composition and its application. Background technique [0002] Cardiocerebral ischemia is often secondary to atherosclerosis (AS) in the late stage, which seriously endangers human health and life. Current prevention status: [0003] 1. Western medicine: The goal of the treatment of atherosclerotic cardio-cerebral ischemia is to relieve symptoms. There are 6 types of commonly used drugs: (1) Nitrate drugs, such as nitrates, are the first-line drugs for stable angina. (2) Antithrombotic (coagulant) drugs such as aspirin and clopidogrel are mainly used for stable and unstable angina; anticoagulant drugs such as heparin and hirudin are mainly used for unstable angina and acute myocardial infarction. (3) β-blockers metoprolol, atenolol and carvedilol, arololol, etc., which have α-blocking effects. (4...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K36/87A61K36/899A61P9/10A61K31/185A61K31/197A61K35/62
CPCA61K31/185A61K31/197A61K35/62A61K36/05A61K36/062A61K36/258A61K36/537A61K36/68A61K36/87A61K36/899A61K2300/00
Inventor 万光瑞牛慧芳朱茉莉荆云牛秉轩潘国聘赵繁荣李鹏张玉珍杨英蕾罗虎
Owner XINXIANG MEDICAL UNIV
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com